• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in

Blog

Featured post

Regulatory-grade device evidence reimagined with new precision data

By linking unique device identifier (UDI) data with minute-level Admission–Discharge–Transfer (ADT), procedure logs, and chargemaster data, Truveta delivers the full picture of when, how, and in what context devices are used—accelerating regulatory submissions, health economics and outcomes research (HEOR), safety monitoring, and more.

Read more
RWD RWE medical device research safety effectiveness HEOR EHR chargemaster unique device identifier ADT ICU procedure logs
Research
Data
Technology
News & events
In this study, Truveta Research explores patterns of GLP-1 RA medication switching from 2018 to 2023 and demographic characteristics of patients who switched.
ResearchResearch Insights

ISPE 2024: Real-world patterns in GLP-1 RA switching from 2018-2023 in the US

  • Truveta Research
  • August 22, 2024
Truveta on GeekWire top startup list
News

Truveta moves up on GeekWire’s Top 200 startup list

  • Truveta staff
  • August 19, 2024
psoriasis and psoriatic arthritis in Truveta Data the most complete, timely, and clean EHR data
Research

Advancing psoriasis research with regulatory-grade EHR data

  • Truveta staff
  • August 15, 2024
Truveta Research uses EHR data to explore medication switching trends from Humira to approved biosimilars following the CVS formulary changes
ResearchResearch Insights

Exploring medication switching trends from Humira to approved biosimilars

  • Truveta Research
  • August 6, 2024
ovarian cancer EHR data
Research

Improving ovarian cancer outcomes with EHR data

  • Truveta staff
  • July 30, 2024
Truveta CTO Jay Nanduri discusses Truveta's approach to healthcare AI and LLMs to make the richness of EHR data available for medical research.
News

Scaling AI models for growth

  • Truveta staff
  • July 30, 2024
Truveta Research in collaboration with Ezekiel Emanuel, MD, PhD, explored trends and factors in the stopping and restarting of GLP-1 medications
Research

Truveta Research leads first study to explore GLP-1 reinitiation trends and factors

  • Truveta Research
  • July 30, 2024
In partnership with STAT News, Truveta Research explored trends in the incidence of testing and diagnosis of PVD/PAD among U.S. patients aged 50 years and older from 2018 to 2024.
ResearchResearch Insights

Trends in testing and diagnosis of peripheral vascular disease in the US

  • Truveta Research
  • July 25, 2024
Truveta Research explores prescribing and dispensing trends for GLP-1 medications labeled for type 2 diabetes and obesity from January 2018 through June 2024.
Research

GLP-1 RA prescription trends: January 2018 – June 2024

  • Truveta Research
  • July 23, 2024
« Previous 1 … 13 14 15 16 17 … 41 Next »

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.